These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1758524)

  • 1. Acute effects of ciclosporin on renal hemodynamics and urinary protein excretion in patients with the nephrotic syndrome.
    Fuiano G; Conte G; Sepe V; Balletta M; Cianfrone P; Libetta C; Romano G; Sabbatini M; Bisesti V
    Nephron; 1991; 59(3):369-74. PubMed ID: 1758524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
    Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria-lowering effect of heparin therapy in diabetic nephropathy without affecting the renin-angiotensin-aldosterone system.
    Benck U; Haeckel S; Clorius JH; van der Woude FJ
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):58-67. PubMed ID: 17699388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of proteinuria by indomethacin in patients with nephrotic syndrome.
    Alavi N; Lianos EA; Venuto RC; Mookerjee BK; Bentzel CJ
    Am J Kidney Dis; 1986 Dec; 8(6):397-403. PubMed ID: 3468803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute haemodynamic and proteinuric effects of prednisolone in patients with a nephrotic syndrome.
    Reichert LJ; Koene RA; Wetzels JF
    Nephrol Dial Transplant; 1999 Jan; 14(1):91-7. PubMed ID: 10052484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects.
    Conte G; Dal Canton A; Sabbatini M; Napodano P; De Nicola L; Gigliotti G; Fuiano G; Testa A; Esposito C; Russo D
    Kidney Int; 1989 Dec; 36(6):1086-92. PubMed ID: 2601257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
    Bech JN; Nielsen CB; Pedersen EB
    Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of the nephrotic syndrome with indomethacin.
    Donker AJ; Brentjens JR; van der Hem GK; Arisz L
    Nephron; 1978; 22(4-6):374-81. PubMed ID: 740100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II local hyperreactivity in the progression of IgA nephropathy.
    Coppo R; Amore A; Gianoglio B; Cacace G; Picciotto G; Roccatello D; Peruzzi L; Piccoli G; De Filippi PG
    Am J Kidney Dis; 1993 Jun; 21(6):593-602. PubMed ID: 8503412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics.
    Thomas DM; Hillis AN; Coles GA; Davies M; Williams JD
    Am J Kidney Dis; 1991 Jul; 18(1):38-43. PubMed ID: 1712151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.
    Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M
    Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular filtration rate is increased in man by the infusion of both D,L-3-hydroxybutyric acid and sodium D,L-3-hydroxybutyrate.
    Fioretto P; Trevisan R; Velussi M; Cernigoi A; De Riva C; Bressan M; Doria A; Pauletto N; Angeli P; De Donà C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):331-8. PubMed ID: 3298305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function during recovery from minimal lesions nephrotic syndrome.
    Koomans HA; Boer WH; Dorhout Mees EJ
    Nephron; 1987; 47(3):173-8. PubMed ID: 3317090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
    Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
    Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis.
    Edwards BD; Chalmers RJ; O'Driscoll JB; Mitchell DM; Smith RJ; Lawson RS; Testa HJ; Ballardie FW
    Clin Nephrol; 1994 Jun; 41(6):350-6. PubMed ID: 8076438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian rhythms in systemic hemodynamics and renal function in healthy subjects and patients with nephrotic syndrome.
    Voogel AJ; Koopman MG; Hart AA; van Montfrans GA; Arisz L
    Kidney Int; 2001 May; 59(5):1873-80. PubMed ID: 11318959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome.
    Remuzzi A; Schieppati A; Battaglia C; Remuzzi G
    Am J Kidney Dis; 1989 Sep; 14(3):170-7. PubMed ID: 2476029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.